New ADHD Medication VYVANSE Now Available
eMaxHealth.com, NC -Jul 28, 2007
Shire plc's VYVANSE , a new once-daily ...
Original post: Shire's New ADHD medication, VYVANSE(TM) (lisdexamfetamine ... - CNNMoney.com by ©2007 Google at vyvanse - Google News
More News About Vyvanse
Posted by Vyvanse (Vyvanse) on Mon, 06 Aug 2007 23:15:37 +0000
Earlier I’ve written about Vyvanse (lisdexamfetamine dimesylate, or LDX), the interesting new central nervous system stimulant. It’sa comboination of dextroamphetamine and lysine, an amino acid. There’s more to report on this new ...
Vyvanse - The New Medicine for ADD/ADHD
Vyvanse is a new ADD/ADHD drug manufactured by Shire that was approved by the FDA in February 2007 to treat ADD/ADHD symptoms in children aged 6 through 12. It is a prodrug, which means that it must be orally ingested to activate its ...
Shire gearing up for Vyvanse launch
Shire has amassed a 560-person sales force in advance of its Monday launch of new attention deficit hyperactivity drug Vyvanse.
Vyvanse
Vyvanse is an extremely interesting new treatment for ADHD that has just been approved by the FDA and should be available in the United States in the very near future. It is manufactured by Shire Pharmaceuticals that is getting a ...
Vyvanse: No Addiction with ADD/ADHD Medication
What’s the difference with Vyvanse? Because Vyvanse is a ‘pro-drug’, it cannot be abused. A pro-drug means that the active medicine is bound to a protein, so it doesn’t work as an amphetamine when it is first taken. ......
Original post: More News About Vyvanse by at Google Blog Search: vyvanse
A slow year so far for innovative drugs
Posted by Vyvanse (Vyvanse) on Sun, 05 Aug 2007 23:15:45 +0000
LabTechnologist.com - New River Pharmaceuticals' (now acquired by Shire) Vyvanse (lisdexamfetamine) for Attention Deficit Hyperactivity Disorder (ADHD); Tekturna (Aliskiren) from Novartis and Speedel, which treats hypertension; another high blood pressure drug from Gilead ...
Brokers' reports help offset housebuilder dip
Guardian Unlimited - JP Morgan said the company could underperform in terms of being able to successfully switch patients from Adderall XR, its attention deficit hyperactivity disorder treatment, to its new product Vyvanse. "There is real downside risk if Shire fails to ... ...
Original post: A slow year so far for innovative drugs by Copyright © 2007 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Live Search results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions. at Live Search News: vyvanse
Shire's new ADHD medication now available - Pharmaceutical Business Review
Posted by Vyvanse (Vyvanse) on Sun, 05 Aug 2007 00:15:47 +0000
Shire's new ADHD medication now available
Pharmaceutical Business Review -Jul 31, 2007
By Staff Writer Shire says Vyvanse, its once-daily medication approved to treat the symptoms of attention deficit hyperactivity disorder, is now available ...
|
Shire eyes regenerative surgery market - Telegraph.co.ukShire eyes regenerative surgery market
Telegraph.co.uk, United Kingdom -Jul 26, 2007
The company said the launch of Vyvanse, its latest product for attention deficit, had exceeded expectations. Vyvanse is the first slow-release ADHD product ...
|
Shire Reports $1.81 Billion Loss After Acquisition (Update1) - BloombergShire Reports $1.81 Billion Loss After Acquisition (Update1)
Bloomberg -Jul 26, 2007
Shire in April paid $2.6 billion for partner New Ri...
Original post: Shire's new ADHD medication now available - Pharmaceutical Business Review by ©2007 Google at vyvanse - Google News
AMRI Announces Second Quarter Results
Posted by Vyvanse (Vyvanse) on Sat, 04 Aug 2007 23:15:22 +0000
TMCnet - ... to achieve anticipated revenues and earnings, costs related to the acquisition and any goodwill impairment related to such investments and acquisitions, the risks posed by international operations to the company, the commercial success of Vyvanse(TM ...
A slow year so far for innovative drugs
LabTechnologist.com - New River Pharmaceuticals' (now acquired by Shire) Vyvanse (lisdexamfetamine) for Attention Deficit Hyperactivity Disorder (ADHD); Tekturna (Aliskiren) from Novartis and Speedel, which treats hypertension; another high blood pressure drug from Gilead ...
Brokers' reports help offset housebuilder dip
Guardian Unlimited - JP Morgan said the company could underperform in terms of being able to successfully switch patients from Adderall XR, its attention deficit hyperactivity disorder treatment, to its new product Vyvanse. "There is real downside risk if Shire fails to ... ...
Original post: AMRI Announces Second Quarter Results by Copyright © 2007 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Live Search results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions. at Live Search News: vyvanse
New ADHD Drug available - WKYC-TV
Posted by Vyvanse (Vyvanse) on Sun, 29 Jul 2007 03:15:31 +0000
New ADHD Drug available
WKYC-TV, OH -Jul 25, 2007
Earlier this year the FDA approved Vyvanse, a once-daily treatment that provides consistent ADHD symptom control. According to the manufacturer, Shire plc, ...
|
Shire raises annual revenue guidance; Q2 underlying earnings rise ... - HemscottVYVANSE(TM) Drug for the Treatment of ADHD in Adults - MedIndiaVYVANSE(TM) Drug for the Treatment of ADHD in Adults
MedIndia, India -Jul 3, 2007
"We are pleased with the results of VYVANSE studies conducted in adults and we believe this prod...
Original post: New ADHD Drug available - WKYC-TV by ©2007 Google at vyvanse - Google News
Vyvanse Information from Drugs.com
Posted by Vyvanse (Vyvanse) on Sun, 29 Jul 2007 00:17:22 +0000
Vyvanse information from Drugs.com, includes Vyvanse side effects, interactions and indications. ... Do not use Vyvanse if you have used an MAO inhibitor such ...
Vyvanse
Vyvanse, Attention Deficit Disorder, Vyvanse is a new that has been approved by the ... ADD Primer Related Conditions Medications Therapies FAQ and ...
Vyvanse ADHD Treatment: from the makers of Adderall XR
Once-daily medication for the treatment of ADHD and ADD. From Shire.
medication guide for vyvanse (lisdexamfetamine dimesylate)
... the Medication Guide that comes with Vyvanse before you or your child starts ... taking Vyvanse, especially seeing or hearing things that ...
FDA approves first and only stimulant prodrug VYVANSE as a novel ADHD treatment
... marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known ... VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body. ......
Original post: Vyvanse Information from Drugs.com by Copyright (c) 2007 Yahoo! Inc. All rights reserved. at Yahoo! Search: vyvanse
Shire eyes regenerative surgery market (Daily Telegraph)
Posted by Vyvanse (Vyvanse) on Sat, 28 Jul 2007 16:52:15 +0000
Shire, the UK's third biggest drugs maker, wants to expand its footprint in the "regenerative surgery" market after striking a licensing deal over a scar repair drug last month.
FTSE dives on credit woes and results (Interactive Investor)
Business Finance and city news online from Interactive Investor (www.iii.co.uk). Plus financial and currency market news and information 24/7. Stock prices, share prices, currency markets news and business finance headlines. Also news from AFX and Reuters.
FTSE at near four-month low on credit woes (Tiscali)
The FTSE 100 ended down 203.1 points, or 3.2 percent, at 6,251.2 to their lowest close since in almost four months. Banking and mining sectors were worst hit by the economic jitters, with HBOS down 3.1 percent and Northern Rock falling 5.8 percent.
Global stocks slide (Stuff)
The FTSE 100 of leading shares slid by the biggest one-day per centage since March 2003 on Thursday as a flurry of corporate results failed to offset losses driven by concerns over a US credit crisis.
FTSE at near four-month low (Reuters via Yahoo! UK & Ireland Finance)
The FTSE 100 <.FTSE> of leading shares slid by the biggest one-day percentage since March 2003 on Thursday as a flurry of corporate results failed to offset losses driven by concerns over a U.S. credit crisis....
Original post: Shire eyes regenerative surgery market (Daily Telegraph) by Copyright (c) 2004 Yahoo! Inc. All rights reserved. at Yahoo! News Search Results for vyvanse
Pages: Start 1 2
|
|
|
